首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1953987

日本分子診斷市場報告：按產品、技術、應用、最終用戶和地區分類（2026-2034年）

Japan Molecular Diagnostics Market Report by Product, Technology (Polymerase Chain Reactions, Hybridization, DNA Sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology, and Others), Application, End User, and Region 2026-2034

出版日期: 2026年02月01日 | 出版商:

IMARC | 英文 138 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本分子診斷市場規模達13億美元。 IMARC Group預測，到2034年，該市場規模將達到22億美元，2026年至2034年的複合年成長率（CAGR）為5.90%。癌症和心血管疾病等慢性病的增加、老年人口的成長（老年人有特殊的醫療需求，患有某些疾病的風險也更高）以及次世代定序和即時PCR等先進技術的應用，都是推動市場成長的關鍵因素。

分子診斷是指用於分析基因組和蛋白質組中生物標記的一系列技術。這個診斷類別使醫療專業人員能夠檢測和測量與特定健康狀況和疾病相關的遺傳物質和蛋白質的存在。分子診斷的特點是精確、準確和快速，並在醫療保健系統中發揮至關重要的作用。這些診斷方法利用聚合酵素鏈鎖反應(PCR)、原位雜合反應(ISH) 和 DNA定序等技術來揭示特定的遺傳訊息。其作用機制包括遺傳物質的萃取、擴增和分析，首先分離 DNA 或 RNA，然後擴增目標基因區域。擴增的遺傳物質隨後使用各種技術進行檢測，以識別突變和改變，使醫療專業人員能夠做出明智的診斷和治療決策。分子診斷的特性，例如靈敏度、特異性和同時處理多個檢體的能力，在提供及時和個人化醫療保健方面具有優勢，並為個人化醫療提供了一個前景廣闊的系統。

日本分子診斷市場的發展趨勢：

日本市場的主要驅動力是慢性病（包括癌症和心血管疾病）的增加，促使人們對早期精準檢測的需求日益成長。而這又受到老年人口不斷增加的推動，老年人口的特殊醫療需求以及患有某些疾病風險的增加。此外，次世代定序和即時PCR等先進技術的整合也是推動市場成長的關鍵因素。同時，日本政府持續提供的財政支持和有利的監管政策也為研發創造了更有利的環境。此外，人們對個人化醫療的認知不斷提高，以及學術機構和私人企業之間研究合作的日益重視，都為市場創造了盈利的機會。分子診斷平台在各種醫療機構的廣泛應用也對市場產生了正面影響。此外，對醫療基礎設施的大力投資以及公共衛生目標與技術創新之間的策略性結合也在推動市場發展。以預防保健和早期診斷為重點的健康保險的普及，以及專業實驗室和診所數量的不斷增加，也都在推動市場成長。其他市場成長要素包括日本受過高等教育的勞動力、先進的醫療保健系統以及重視醫學科學和技術的精準性和創新性的文化背景。

日本分子診斷市場細分：

產品洞察：

本報告解答的關鍵問題：

目前日本分子診斷市場的發展趨勢是什麼？您對未來幾年的發展趨勢有何預測？
新冠疫情對日本分子診斷市場產生了哪些影響？
日本分子診斷市場的產品組成是怎樣的？
日本分子診斷市場按技術是如何細分的？
日本分子診斷市場按應用領域分類的組成是怎樣的？
日本分子診斷市場依最終用戶分類的組成是怎樣的？
請介紹一下日本分子診斷市場價值鏈的各個環節。
日本分子診斷市場的主要促進因素和挑戰是什麼？
日本分子診斷市場的結構是怎麼樣的？主要參與者有哪些？
日本分子診斷市場的競爭程度如何？

The Japan molecular diagnostics market size reached USD 1.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.2 Billion by 2034, exhibiting a growth rate (CAGR) of 5.90% during 2026-2034. The increasing prevalence of chronic diseases, including cancer and cardiovascular ailments, the growing geriatric population requiring unique healthcare needs and a higher propensity for specific diseases, and the integration of advanced technologies such as next-generation sequencing and real-time PCR represent some of the key factors driving the market.

Molecular diagnostics refers to a collection of techniques used to analyze biological markers in the genome and proteome. This category of diagnostics enables medical professionals to detect and measure the presence of genetic material or proteins associated with a specific health condition or disease state. Molecular diagnostics are characterized by their precision, accuracy, and speed, as well as their essential role in the healthcare system. These diagnostic methods employ technologies such as PCR (polymerase chain reaction), ISH (in situ hybridization), and DNA sequencing to uncover specific genetic information. Their working mechanism involves extracting, amplifying, and analyzing genetic material, starting with the isolation of DNA or RNA to amplify targeted genetic regions. The amplified genetic material is then examined through various methods to identify mutations or changes, enabling healthcare providers to make informed decisions about diagnosis and treatment. The properties of molecular diagnostics such as sensitivity, specificity, and the ability to process multiple samples simultaneously make them advantageous in providing timely and tailored medical treatments, thereby offering a promising system to personalized medicine.

Japan Molecular Diagnostics Market Trends:

The market in Japan is primarily driven by the increasing prevalence of chronic diseases, including cancer and cardiovascular ailments, which necessitates the need for early and precise detection. In line with this, the growing geriatric population in Japan, requiring unique healthcare needs and a higher propensity for specific diseases, is also providing an impetus to the market. Moreover, the integration of advanced technologies such as next-generation sequencing and real-time PCR is acting as a significant growth-inducing factor for the market. In addition to this, the consistent support from the Japanese government in terms of funding and favorable regulatory guidelines is resulting in a more conducive environment for research and development. Besides this, the growing awareness about personalized medicine, coupled with a strong emphasis on research collaboration between academic institutions and private enterprises, is creating lucrative opportunities in the market. Also, the wide availability of molecular diagnostic platforms across various healthcare settings is impacting the market positively. The market is further driven by the robust investment in healthcare infrastructure and the strategic alignment of public health goals with technological innovation. Apart from this, the penetration of health insurance, focusing on preventive care and early diagnosis, along with the proliferation of specialized laboratories and clinics, is propelling the market. Some of the other factors contributing to the market include Japan's highly educated workforce, sophisticated healthcare system, and a cultural emphasis on precision and innovation in medical science and technology.

Japan Molecular Diagnostics Market Segmentation:

Product Insights:

Reagents and Kits
Instruments
Software and Services

Technology Insights:

Polymerase Chain Reactions (PCR)
Hybridization
DNA Sequencing
Microarray
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others

Application Insights:

Infectious Diseases Diagnostics
Oncology
Genetic Testing
Blood Screening
Others

End User Insights:

Hospitals
Laboratories
Others

Regional Insights:

Kanto Region
Kinki Region
Central/Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan molecular diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan molecular diagnostics market?
What is the breakup of the Japan molecular diagnostics market on the basis of product?
What is the breakup of the Japan molecular diagnostics market on the basis of technology?
What is the breakup of the Japan molecular diagnostics market on the basis of application?
What is the breakup of the Japan molecular diagnostics market on the basis of end user?
What are the various stages in the value chain of the Japan molecular diagnostics market?
What are the key driving factors and challenges in the Japan molecular diagnostics market?
What is the structure of the Japan molecular diagnostics market and who are the key players?
What is the degree of competition in the Japan molecular diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Molecular Diagnostics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Molecular Diagnostics Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Molecular Diagnostics Market - Breakup by Product

6.1 Reagents and Kits
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Instruments
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Software and Services
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)

7 Japan Molecular Diagnostics Market - Breakup by Technology

7.1 Polymerase Chain Reactions (PCR)
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Hybridization
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 DNA Sequencing
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Microarray
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)
7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2020-2025)
- 7.5.3 Market Forecast (2026-2034)
7.6 Others
- 7.6.1 Historical and Current Market Trends (2020-2025)
- 7.6.2 Market Forecast (2026-2034)

8 Japan Molecular Diagnostics Market - Breakup by Application

8.1 Infectious Diseases Diagnostics
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Oncology
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Genetic Testing
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)
8.4 Blood Screening
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Forecast (2026-2034)
8.5 Others
- 8.5.1 Historical and Current Market Trends (2020-2025)
- 8.5.2 Market Forecast (2026-2034)

9 Japan Molecular Diagnostics Market - Breakup by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Laboratories
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)
9.3 Others
- 9.3.1 Historical and Current Market Trends (2020-2025)
- 9.3.2 Market Forecast (2026-2034)

10 Japan Molecular Diagnostics Market - Breakup by Region

10.1 Kanto Region
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Breakup by Product
- 10.1.4 Market Breakup by Technology
- 10.1.5 Market Breakup by Application
- 10.1.6 Market Breakup by End User
- 10.1.7 Key Players
- 10.1.8 Market Forecast (2026-2034)
10.2 Kinki Region
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Breakup by Product
- 10.2.4 Market Breakup by Technology
- 10.2.5 Market Breakup by Application
- 10.2.6 Market Breakup by End User
- 10.2.7 Key Players
- 10.2.8 Market Forecast (2026-2034)
10.3 Central/ Chubu Region
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Breakup by Product
- 10.3.4 Market Breakup by Technology
- 10.3.5 Market Breakup by Application
- 10.3.6 Market Breakup by End User
- 10.3.7 Key Players
- 10.3.8 Market Forecast (2026-2034)
10.4 Kyushu-Okinawa Region
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2020-2025)
- 10.4.3 Market Breakup by Product
- 10.4.4 Market Breakup by Technology
- 10.4.5 Market Breakup by Application
- 10.4.6 Market Breakup by End User
- 10.4.7 Key Players
- 10.4.8 Market Forecast (2026-2034)
10.5 Tohoku Region
- 10.5.1 Overview
- 10.5.2 Historical and Current Market Trends (2020-2025)
- 10.5.3 Market Breakup by Product
- 10.5.4 Market Breakup by Technology
- 10.5.5 Market Breakup by Application
- 10.5.6 Market Breakup by End User
- 10.5.7 Key Players
- 10.5.8 Market Forecast (2026-2034)
10.6 Chugoku Region
- 10.6.1 Overview
- 10.6.2 Historical and Current Market Trends (2020-2025)
- 10.6.3 Market Breakup by Product
- 10.6.4 Market Breakup by Technology
- 10.6.5 Market Breakup by Application
- 10.6.6 Market Breakup by End User
- 10.6.7 Key Players
- 10.6.8 Market Forecast (2026-2034)
10.7 Hokkaido Region
- 10.7.1 Overview
- 10.7.2 Historical and Current Market Trends (2020-2025)
- 10.7.3 Market Breakup by Product
- 10.7.4 Market Breakup by Technology
- 10.7.5 Market Breakup by Application
- 10.7.6 Market Breakup by End User
- 10.7.7 Key Players
- 10.7.8 Market Forecast (2026-2034)
10.8 Shikoku Region
- 10.8.1 Overview
- 10.8.2 Historical and Current Market Trends (2020-2025)
- 10.8.3 Market Breakup by Product
- 10.8.4 Market Breakup by Technology
- 10.8.5 Market Breakup by Application
- 10.8.6 Market Breakup by End User
- 10.8.7 Key Players
- 10.8.8 Market Forecast (2026-2034)

11 Japan Molecular Diagnostics Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Services Offered
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Services Offered
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Services Offered
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Services Offered
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Services Offered
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan Molecular Diagnostics Market - Industry Analysis

13.1 Drivers, Restraints, and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis